A61K8/345

Polymeric composite particles

Compositions are provided that include a matrix and a polymeric composite particles disposed in the matrix. The polymeric composite particles include a porous polymeric core and a fragrance positioned within the porous polymeric core. Polymeric composite particles are also provided including a porous polymeric core, a fragrance positioned within the porous polymeric core, and a coating layer around the porous polymeric core. Further, a method of determining a minimum temperature of a composition is provided including providing a composition including polymeric composite particles disposed in a matrix, heating the composition, releasing at least a portion of the fragrance as a vapor from the porous polymeric core of the polymeric composite particles at or above the minimum temperature, and detecting at least a portion of the fragrance vapor in a location outside of the matrix.

Process for curl-relaxing and/or straightening keratin fibres, using reducing agents and polar organic solvents, and straightening kit
11504317 · 2022-11-22 ·

The present invention relates to a process for curl-relaxing and/or straightening keratin fibres, such as the hair, which comprises the application to the fibres of one or more compositions comprising reducing agents, one or more compositions comprising organic solvents and a step of heat treatment of the fibres by means of a heating tool. The invention also relates to the use of the composition(s) comprising reducing agents and of the composition(s) comprising organic solvents in a process for curl-relaxing and/or straightening keratin fibres. Finally, the invention relates to a multi-compartment device or “kit” that is suitable for performing such a process.

Composition of lipoamino acids and alkanediols, process for the preparation thereof, and cosmetic or pharmaceutical composition resulting therefrom

Disclosed are a new composition of lipoamino acids and alkanediols, a process for the preparation thereof, and a cosmetic or pharmaceutical composition resulting therefrom.

Deo emulsion for aerosols, deodorant comprising the same and use of the deodorant

The present disclosure concerns a deodorant emulsion for an aerosol spray which is free from aluminum salts and ethanol, comprising: at least one emulsifier, at least one salt, water, at least one silicone oil and at least one further oil, and a deodorant aerosol spray product comprising a pressure or pump spray container with spray head, the filling of which comprises the deodorant emulsion and optionally a propellant and/or further solvent, and a use of the deodorant aerosol spray product for deodorizing human skin.

HIGH GLYCEROL COMPOSITION COMPRISING BLENDS OF ALKYL ISETHIONATE AND ALKYL TAURATE

The invention related to high glycerol compositions comprising blends of alkyl isethionate and alkyl taurate. Selecting specific ratios of isethionate to taurate allows preparation of high glycerol liquids while minimizing amphoteric, all while retaining clear, isotropic liquid.

COSMETIC COMPOSITION
20230058072 · 2023-02-23 ·

The invention pertains to a cosmetic composition comprising: at least one saponin; and at least one prebiotic component selected from the group consisting of fructooligosaccharides, fructans, galactooligosaccharides, galactans, glucooligosaccharides, glucans, pectin, xylooligosaccharides, xylans, and mixtures thereof. The invention also pertains to a process for producing such a cosmetic composition and to a use of said cosmetic composition.

COMPOSITION COMPRISING HYALURONIC ACID AND A POLYOL AND/OR CARBOXYMETHYL CELLULOSE
20230054346 · 2023-02-23 ·

The invention relates to a composition comprising at least hyaluronic acid and at least one polyol and/or carboxymethyl cellulose (CMC).

The invention also relates to the use of at least one polyol and/or carboxymethyl cellulose to stabilize hyaluronic acid in a composition.

METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN HYDROXYCARBOXYLIC ACID ESTER, A DIOL AND A DYEING COMPOUND

The subject of the present disclosure is a method for dyeing keratinous material, in particular human hair, comprising the following steps: Application of an agent (a) to the keratinous material, wherein the agent (a) comprises: (a1) at least one organic silicon compound selected from the group of silanes having one, two or three silicon atoms, and
(a2) at least one hydroxycarboxylic acid ester,
(a3) at least one diol and Application of an agent (b) to the keratinous material, wherein the agent (b) comprises: (b1) at least one sealing reagent,
wherein at least one of the agents (a) and (b) further comprises at least one colorant compound selected from the group of pigments and/or direct dyes.

Sulfate-Free Surfactant System
20230053407 · 2023-02-23 ·

Provided is a sulfate-free surfactant system which is particularly suitable for use in personal hygiene products. The sulfate-free surfactant system comprises a liquid comprising an organic phase and a solvent wherein the organic phase comprises glyceride and surfactant and the liquid comprises: 4-40 wt % glyceride wherein the glyceride is the condensation reaction product of at least 1.10 moles of a mixture of acids to no more than 2.1 moles of mixture of acids per mole of glycerin; wherein mixture of acids comprises: at least 0.275 to no more than 0.990 moles of a first acid comprising a branched acid with 16-20 aliphatic carbons; at least 0.250 to no more than 0.810 moles of a second acid comprising an alkyl acid with 9-11 carbons; and at least 0.250 to no more than 0.810 moles of a third acid comprising an alkyl acid with 7-9 carbons wherein the third acid has a lower molecular weight than the second acid; and 6-45 wt % surfactant; and wherein the liquid has a BYV of at least 50 dyn/cm.sup.2.

PHARMACEUTICAL FORMULATION FOR INHIBITING BODY MALODOUR

There is provided a pharmaceutical formulation comprising an anticholinergic agent and a ternary solvent comprising 5% to 15% v/v glycol, 60% to 70% v/v alcohol and 5% to 20% v/v water. There is also provided a method of preparing the pharmaceutical formulation as disclosed herein, comprising the step of mixing the anticholinergic agent to a mixture containing alcohol, glycol, water, humectant and pH buffering agent at room temperature. There is also provided a method of inhibiting non-pathological body malodour in a mammal. There is also provided a method of treating apocrine secretion causing odour and reduction of microbial overgrowth in a mammalian subject, and uses of a pharmaceutical formulation.